Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13151
PUT
ARKO Corp
ARKO
$476M
| $19.8K | ﹤0.01% |
3,000
-35,400
| -92% | -$244K |
2023 Q3
5 quarters
|
|
13152
CALL
Atossa Therapeutics
ATOS
$24.7M
| $19.7K | ﹤0.01% |
1,393
-3,114
| -69% | -$60.8K |
2020 Q2
18 quarters
|
|
13153
PUT
GCM Grosvenor
GCMG
$812M
| $19.6K | ﹤0.01% |
1,600
+1,500
| +1,500% | +$17.8K |
2024 Q1
3 quarters
|
|
13154
PUT
Q32 Bio
QTTB
$246M
| $19.6K | ﹤0.01% |
+5,700
| New | +$180K |
2024 Q4
0 quarters
|
|
13155
CALL
ThredUp
TDUP
$285M
| $19.6K | ﹤0.01% |
14,100
-21,800
| -61% | -$24.5K |
2021 Q2
14 quarters
|
|
13156
CALL
HF Foods Group
HFFG
$87.9M
| $19.6K | ﹤0.01% |
6,100
-1,800
| -23% | -$6.3K |
2024 Q1
3 quarters
|
|
13157
CALL
Dakota Gold
DC
$785M
| $19.6K | ﹤0.01% |
8,900
-12,200
| -58% | -$27.5K |
2023 Q4
4 quarters
|
|
|
ELP
13158
CALL
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $19.6K | ﹤0.01% |
3,300
+3,100
| +1,550% | +$20.5K |
2022 Q1
11 quarters
|
|
13159
PUT
KRONOS Worldwide
KRO
$921M
| $19.5K | ﹤0.01% |
2,000
+700
| +54% | +$7.86K |
2022 Q4
8 quarters
|
|
13160
PUT
Gold Royalty Corp
GROY
$681M
| $19.5K | ﹤0.01% |
16,100
-10,700
| -40% | -$14.3K |
2021 Q2
14 quarters
|
|
13161
Adicet Bio
ACET
$60.4M
| $19.5K | ﹤0.01% |
1,265
-1,429
| -53% | -$27K |
2021 Q4
12 quarters
|
|
13162
CALL
KraneShares China Internet and Covered Call Strategy ETF
KLIP
$90.7M
| $19.4K | ﹤0.01% |
+600
| New | +$20.7K |
2024 Q4
0 quarters
|
|
|
INGM
13163
PUT
Ingram Micro Holding
INGM
$6.48B
| $19.4K | ﹤0.01% |
+1,000
| New | +$22.4K |
2024 Q4
0 quarters
|
|
|
CODX
13164
CALL
Co-Diagnostics
CODX
$7.82M
| $19.4K | ﹤0.01% |
860
+557
| +184% | +$17.6K |
2020 Q1
19 quarters
|
|
|
CNTB
13165
CALL
Connect Biopharma Holdings
CNTB
$58.8M
| $19.3K | ﹤0.01% |
+14,000
| New | +$16.1K |
2024 Q4
0 quarters
|
|
|
MITT
13166
PUT
TPG Mortgage Investment Trust
MITT
$182M
| $19.3K | ﹤0.01% |
2,900
+2,200
| +314% | +$15.6K |
2024 Q3
1 quarter
|
|
|
TPIC
13167
PUT
DELISTED
TPI Composites
TPIC
| $19.3K | ﹤0.01% |
10,200
+3,900
| +62% | +$10.8K |
2022 Q3
9 quarters
|
|
13168
CALL
YieldMax GOOGL Option Income Strategy ETF
GOOY
$229M
| $19.3K | ﹤0.01% |
+1,300
| New | +$19.6K |
2024 Q4
0 quarters
|
|
13169
CALL
Peapack-Gladstone Financial
PGC
$793M
| $19.2K | ﹤0.01% |
600
-700
| -54% | -$23.2K |
2024 Q1
3 quarters
|
|
|
RMAX
13170
PUT
DELISTED
RE/MAX Holdings
RMAX
| $19.2K | ﹤0.01% |
1,800
-1,900
| -51% | -$22.8K |
2023 Q3
5 quarters
|
|
13171
CALL
Duluth Holdings
DLTH
$155M
| $19.2K | ﹤0.01% |
6,200
-9,200
| -60% | -$33.4K |
2019 Q2
22 quarters
|
|
13172
CALL
Financial Institutions
FISI
$783M
| $19.1K | ﹤0.01% |
700
-300
| -30% | -$7.89K |
2022 Q4
8 quarters
|
|
13173
Lexicon Pharmaceuticals
LXRX
$779M
| $19.1K | ﹤0.01% |
25,832
-72,792
| -74% | -$87.7K |
2021 Q1
15 quarters
|
|
13174
Global X MLP & Energy Infrastructure ETF
MLPX
$3.51B
| $19.1K | ﹤0.01% |
315
-5,640
| -95% | -$336K |
2024 Q1
3 quarters
|
|
|
UFOX
13175
PUT
Defiance Space and Connective Tech ETF
UFOX
$926M
| $19.1K | ﹤0.01% |
400
| – | – |
2024 Q3
1 quarter
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.